733 related articles for article (PubMed ID: 28294066)
1. Mechanisms of Melatonin in Alleviating Alzheimer's Disease.
Shukla M; Govitrapong P; Boontem P; Reiter RJ; Satayavivad J
Curr Neuropharmacol; 2017; 15(7):1010-1031. PubMed ID: 28294066
[TBL] [Abstract][Full Text] [Related]
2. Protective roles of melatonin against the amyloid-dependent development of Alzheimer's disease: A critical review.
Vincent B
Pharmacol Res; 2018 Aug; 134():223-237. PubMed ID: 29981776
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Attenuates Methamphetamine-Induced Alteration of Amyloid β Precursor Protein Cleaving Enzyme Expressions via Melatonin Receptor in Human Neuroblastoma Cells.
Nopparat C; Boontor A; Panmanee J; Govitrapong P
Neurotox Res; 2022 Aug; 40(4):1086-1095. PubMed ID: 35648367
[TBL] [Abstract][Full Text] [Related]
4. Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.
Hossain MF; Uddin MS; Uddin GMS; Sumsuzzman DM; Islam MS; Barreto GE; Mathew B; Ashraf GM
Mol Neurobiol; 2019 Dec; 56(12):8255-8276. PubMed ID: 31209782
[TBL] [Abstract][Full Text] [Related]
5. Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease.
Li Y; Zhang J; Wan J; Liu A; Sun J
Biomed Pharmacother; 2020 Dec; 132():110887. PubMed ID: 33254429
[TBL] [Abstract][Full Text] [Related]
6. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
[TBL] [Abstract][Full Text] [Related]
7. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.
Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B
J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin.
Rosales-Corral SA; Acuña-Castroviejo D; Coto-Montes A; Boga JA; Manchester LC; Fuentes-Broto L; Korkmaz A; Ma S; Tan DX; Reiter RJ
J Pineal Res; 2012 Mar; 52(2):167-202. PubMed ID: 22107053
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
10. Role of melatonin in Alzheimer-like neurodegeneration.
Wang JZ; Wang ZF
Acta Pharmacol Sin; 2006 Jan; 27(1):41-9. PubMed ID: 16364209
[TBL] [Abstract][Full Text] [Related]
11. Activation of melatonin receptor 1 by CRISPR-Cas9 activator ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Park H; Kim J
J Pineal Res; 2022 Apr; 72(3):e12787. PubMed ID: 35133672
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.
O'Neal-Moffitt G; Delic V; Bradshaw PC; Olcese J
Mol Neurodegener; 2015 Jul; 10():27. PubMed ID: 26159703
[TBL] [Abstract][Full Text] [Related]
14. Melatonin ameliorates Aβ
Chinchalongporn V; Shukla M; Govitrapong P
J Pineal Res; 2018 May; 64(4):e12470. PubMed ID: 29352484
[TBL] [Abstract][Full Text] [Related]
15. Melatonin administration reverses the alteration of amyloid precursor protein-cleaving secretases expression in aged mouse hippocampus.
Mukda S; Panmanee J; Boontem P; Govitrapong P
Neurosci Lett; 2016 May; 621():39-46. PubMed ID: 27068758
[TBL] [Abstract][Full Text] [Related]
16. Long-term oral melatonin alleviates memory deficits, reduces amyloid-β deposition associated with downregulation of BACE1 and mitophagy in APP/PS1 transgenic mice.
Sun C; Qiu X; Wang Y; Liu J; Li Q; Jiang H; Li S; Song C
Neurosci Lett; 2020 Sep; 735():135192. PubMed ID: 32619650
[TBL] [Abstract][Full Text] [Related]
17. Recent Studies on Design and Development of Drugs Against Alzheimer's Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents.
Gupta SP; Patil VM
Curr Top Med Chem; 2020; 20(13):1195-1213. PubMed ID: 32297584
[TBL] [Abstract][Full Text] [Related]
18. Novel melatonin-trientine conjugate as potential therapeutic agents for Alzheimer's disease.
Li LB; Fan YG; Wu WX; Bai CY; Jia MY; Hu JP; Gao HL; Wang T; Zhong ML; Huang XS; Guo C
Bioorg Chem; 2022 Nov; 128():106100. PubMed ID: 35988518
[TBL] [Abstract][Full Text] [Related]
19. Quercetin stimulates the non-amyloidogenic pathway via activation of ADAM10 and ADAM17 gene expression in aluminum chloride-induced Alzheimer's disease rat model.
Elfiky AM; Mahmoud AA; Elreedy HA; Ibrahim KS; Ghazy MA
Life Sci; 2021 Nov; 285():119964. PubMed ID: 34537230
[TBL] [Abstract][Full Text] [Related]
20. Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus.
Panmak P; Nopparat C; Permpoonpattana K; Namyen J; Govitrapong P
Neurochem Int; 2021 Sep; 148():105121. PubMed ID: 34224806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
